Sage Therapeutics Inc. (SAGE)
NASDAQ: SAGE
· Real-Time Price · USD
6.83
-0.03 (-0.44%)
At close: May 07, 2025, 3:59 PM
6.73
-1.54%
After-hours: May 07, 2025, 06:54 PM EDT
-0.44% (1D)
| Bid | 5.46 |
| Market Cap | 428.01M |
| Revenue (ttm) | 47.4M |
| Net Income (ttm) | -354.4M |
| EPS (ttm) | -5.8 |
| PE Ratio (ttm) | -1.18 |
| Forward PE | -2.59 |
| Analyst | Hold |
| Ask | 8 |
| Volume | 468,522 |
| Avg. Volume (20D) | 1,312,183 |
| Open | 6.85 |
| Previous Close | 6.86 |
| Day's Range | 6.78 - 6.92 |
| 52-Week Range | 4.62 - 13.47 |
| Beta | 0.20 |
About SAGE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SAGE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SAGE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Sage Therapeutics has released their quartely earnings
on Apr 29, 2025:
3 months ago
+35.14%
Sage Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
6 months ago
-24.06%
Sage Therapeutics shares are trading lower after the company reported worse-than-expected Q3 EPS results. Additionally, HC Wainwright & Co. cut its price target on the stock from $25 to $14.
